Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort

Chloe L. Thio, Laura Smeaton, Melissa Saulynas, Hyon Hwang, Shanmugam Saravan, Smita Kulkarni, James Hakim, Mulinda Nyirenda, Hussain S. Iqbal, Umesh G. Lalloo, Anand S. Mehta, Kimberly Hollabaugh, Thomas B. Campbell, Shahin Lockman, Judith S. Currier

Research output: Contribution to journalArticlepeer-review

63 Scopus citations


OBJECTIVE: To understand the HIV-hepatitis B virus (HBV) epidemic from a global perspective by clinically and virologically characterizing these viruses at the time of antiretroviral therapy (ART) initiation in a multinational cohort. METHODS AND DESIGN: HIV-infected patients enrolled in two international studies were classified as HIV-HBV coinfected or HIV monoinfected prior to ART. HIV-HBV coinfected patients were tested for HBV characteristics, hepatitis D virus (HDV), a novel noninvasive marker of liver disease, and drug-resistant HBV. Comparisons between discrete covariates used χ or Fisher's exact tests (and Jonchkheere-Terpstra for trend tests), whereas continuous covariates were compared using Wilcoxon Rank-Sum Test. RESULTS: Of the 2105 HIV-infected patients from 11 countries, the median age was 34 years and 63% were black. The 115 HIV-HBV coinfected patients had significantly higher alanine aminotransferase and aspartate aminotransferase values, lower BMI, and lower CD4 T-cell counts than HIV monoinfected patients (median 159 and 137cells/μl, respectively, P=0.04). In the coinfected patients, 49.6% had HBeAg-negative HBV, 60.2% had genotype A HBV, and 13% were HDV positive. Of the HBeAg-negative patients, 66% had HBV DNA 2000IU/ml or less compared to 5.2% of the HBeAg-positive individuals. Drug-resistant HBV was not detected. CONCLUSION: Screening for HBV in HIV-infected patients in resource-limited settings is important because it is associated with lower CD4 T-cell counts. In settings in which HBV DNA is not available, HBeAg may be useful to assess the need for HBV treatment. Screening for drug-resistant HBV is not needed prior to starting ART in settings in which this study was conducted.

Original languageEnglish (US)
Pages (from-to)191-201
Number of pages11
Issue number2
StatePublished - Jan 14 2013


  • HIV
  • coinfection
  • global
  • hepatitis B virus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases


Dive into the research topics of 'Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort'. Together they form a unique fingerprint.

Cite this